Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950162-04-001007
Filing Date
2004-09-07
Accepted
2004-09-07 16:40:29
Documents
2
Period of Report
2004-09-02

Document Format Files

Seq Description Document Type Size
1 regeneform4090704_ex.html 4  
1 regeneform4090704_ex.xml 4 9520
2 JOINT FILER INFORMATION regeneform4090704ex99.txt EX-99 638
  Complete submission text file 0000950162-04-001007.txt   12910
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA SUDAFRICA 20 00144 ROME ITALY
Business Address VIA SUDAFRICA 20 00144 ROME ITALY
SIGMA TAU FINANZIARIA SPA (Reporting) CIK: 0001092601 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-15070 | Film No.: 041018958

Mailing Address RUA DOS FERREIROS,260 FUNCHAL MADEIRA S1 9000-082
Business Address
DEFIANTE FARMACEUTICA LDA (Reporting) CIK: 0001168857 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15070 | Film No.: 041018957